XML 150 R117.htm IDEA: XBRL DOCUMENT v3.10.0.1
Summary of Quarterly Data (Unaudited) (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2017
Sep. 30, 2017
Jun. 30, 2017
Mar. 31, 2017
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Quarterly Financial Data [Abstract]                      
Total revenue $ 549,386 $ 545,448 $ 580,752 $ 537,656 $ 506,121 $ 491,976 $ 508,940 $ 462,021 $ 2,213,242 $ 1,969,058 $ 1,775,423
Gross profit 300,361 305,643 332,439 303,099 272,474 274,002 292,715 258,191 1,241,542 1,097,382 975,436
Operating income 115,347 117,350 145,594 113,044 97,808 100,413 122,564 92,243 491,335 413,028 350,239
Net income attributable to IDEXX Laboratories, Inc. stockholders $ 85,638 $ 93,251 $ 108,691 $ 89,451 $ 38,257 $ 70,511 $ 85,357 $ 69,019 $ 377,031 $ 263,144 $ 222,045
Earnings per Share:                      
Basic (in USD per share) $ 0.99 $ 1.07 $ 1.25 $ 1.02 $ 0.44 $ 0.81 $ 0.97 $ 0.78 $ 4.34 $ 3.00 $ 2.47
Diluted (in USD per share) $ 0.98 $ 1.05 $ 1.23 $ 1.01 $ 0.43 $ 0.79 $ 0.95 $ 0.77 $ 4.26 $ 2.94 $ 2.44